The Kiplinger Monitor - index of pharmaceutical industry - Brief Article - Statistical Data Included
Kiplinger's Personal Finance Magazine, March, 2000 by Catherine Siskos
11%
Estimated average annual increase in insured spending on prescription drugs through 2008, compared with 6% per year for hospital and physician care.
8%
Projected average annual increase in out-of-pocket spending on prescription drugs through 2008.
$3.20
Price of one 300-milligram tablet of the ulcer drug Zantac, compared with 44 cents per pill for the generic version.
$500 MILLION
Average cost from lab to market for one new drug. Only one in 5,000 drugs actually reaches the market.
3 YEARS
Period for which a bill in Congress would extend patents for eight medications to encourage pharmaceutical companies to develop new drugs.
- Most Popular Articles in Business
- Research and Markets : Tesco Plc - SWOT Framework Analysis
- Do Us a Flavor - Ben & Jerry's Issues a Call for Euphoric New Flavors
- eBay made easy: ready to start an eBay business? These 5 simple steps will ...
- Katrina's lawsuit surge: a legal battle to force insurers to pay for flood ...
- Wal-Mart's newest distribution center opened last month near the southwest ...
- More »
$11 BILLION
Estimated cost to consumers for the delay in developing generic alternatives for those eight drugs.
SOURCES: Health Care Financing Administration, Pharmaceutical Research and Manufacturers of America, Prime Institute of the University of Minnesota College of Pharmacy
COPYRIGHT 2000 The Kiplinger Washington Editors, Inc.
COPYRIGHT 2000 Gale Group